Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Did you see the gorgeous sunrise over Scarborough this morning? Well it's only going to get better....
Transport Secretary Chris Grayling is being threatened with legal action over his handling of the failed East Coast rail franchise.
Lovely day ahead, dry with pretty much wall to wall sunshine